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The Imd signaling cascade, similar to the mammalian TNF-
receptor pathway, controls antimicrobial peptide expres-
sion in Drosophila. We performed a large-scale RNAi
screen to identify novel components of the Imd pathway
in Drosophila S2 cells. In all, 6713 dsRNAs from an S2 cell-
derived cDNA library were analyzed for their effect on
Attacin promoter activity in response to Escherichia coli.
We identified seven gene products required for the Attacin
response in vitro, including two novel Imd pathway com-
ponents: inhibitor of apoptosis 2 (Iap2) and transforming
growth factor-activated kinase 1 (TAK1)-binding protein
(TAB). Iap2 is required for antimicrobial peptide response
also by the fat body in vivo. Both these factors function
downstream of Imd. Neither TAB nor Iap2 is required for
Relish cleavage, but may be involved in Relish nuclear
localization in vitro, suggesting a novel mode of regulation
of the Imd pathway. Our results show that an RNAi-based
approach is suitable to identify genes in conserved signal-
ing cascades.
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Introduction
Drosophila melanogaster has developed a highly sophisti-
cated immune defense, which is required for living in a
natural environment that is rich in bacteria and fungi. In
contrast to mammals, Drosophila has no adaptive, that is,
antibody-mediated immunity, which makes it a good model
for studying the pattern recognition receptors and signaling
pathways of innate immunity. In Drosophila, there are two
major pathways that respond to microbes: the Imd and the
Toll pathways. Both of them are strikingly well conserved
throughout evolution (Hoffmann et al, 1999; Hoffmann 2003;
Hultmark 2003). Thus, novel findings from work on
Drosophila immune response can fuel discoveries in the
mammalian systems.
In Drosophila, evolutionarily conserved peptidoglycan
recognition proteins (PGRPs) are of paramount importance
for microbial recognition. Several Drosophila PGRPs are
necessary for normal resistance to bacteria (Michel et al,
2001; Choe et al, 2002; Gottar et al, 2002; Ra¨met et al, 2002;
Takehana et al, 2004). Secreted PGRP-SA is essential for
induction of immune response genes via the Toll pathway
in response to certain Gram-positive bacteria in vivo (Michel
et al, 2001). On the other hand, PGRP-LC is the first compo-
nent of the Imd pathway (Choe et al, 2002; Gottar et al, 2002;
Ra¨met et al, 2002). It is located on the cell membrane where it
appears to act as a pattern recognition receptor for bacteria
either alone or together with other PGRPs (Takehana et al,
2004). Recently, intracellular domain of PGRP-LC was shown
to bind directly to the Imd, which is the next known com-
ponent downstream of PGRP-LC (Choe et al, 2005). Imd
contains a death domain with homology to the mammalian
receptor-interacting protein 1. The signal is propagated via
transforming growth factor-activated kinase 1 (TAK1) to
Drosophila homologs for IKKg and IKKa/b (Key and Ird5,
respectively) (Rutschmann et al, 2000; Lu et al, 2001).
Whether TAK1 phosphorylates the Drosophila IKKs directly
is uncertain and the mechanism of TAK1 activation is
elusive. TAK1 has also been shown to play a role in the
regulation of the c-Jun N-terminal kinase (JNK) pathway
(Park et al, 2004). Finally, the signal leads to the activation
of the Drosophila NF-kB homolog Relish, involving its phos-
phorylation by the IKK complex (Silverman et al, 2000) and
cleavage by a caspase currently believed to be Dredd (Leulier
et al, 2000; Sto¨ven et al, 2000, 2003), which forms a complex
with BG4, a homolog to mammalian Fas-associated death
domain protein (FADD; Leulier et al, 2002). The phosphory-
lated and cleaved Relish is then translocated to the nucleus,
where it binds to DNA leading to synthesis of antimicrobial
peptides.
Genome sequencing projects have created a demand to
develop rapid methods to elucidate the biological function of
individual genes. RNAi is a tool for screening whole genomes
for genes with easily assayed loss-of-function phenotypes.
It has been a feasible method for large-scale screening of
various phenotypes in Drosophila hemocyte-like S2 cells
(Ra¨met et al, 2002) including signaling cascades (Lum et al,
2003), and a genome-wide RNAi screen for S2 cell viability
was published recently (Boutros et al, 2004). In our study, we
first evaluated the specificity and effectiveness of RNAi
treatments in S2 cells, after which we carried out a blind
screen for B6700 dsRNAs to identify novel components of
the Imd signaling cascade.
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Results and discussion
RNAi specifically and effectively decreases the
expression of the targeted gene in S2 cells
RNAi silences the expression of the targeted gene in S2 cells
(Hammond et al, 2000). In order to assay the effectiveness of
RNAi-based gene silencing in our system, we incubated
2.5106 S2 cells in six-well plates containing 3 ml of medium
with or without 10 mg of CG5210 dsRNA for 48 h. CG5210
codes for a chitinase-like protein containing a signal
sequence. After RNAi, expression levels of more than
13 500 transcripts were measured using oligonucleotide
microarrays. Strikingly, only CG5210 mRNA level was
strongly decreased, whereas the rest of the mRNA levels
remained unaffected (Figure 1A), showing that RNAi is
both effective and highly specific in S2 cells.
RNAi phenotypes are reproducible
RNAi-based in vitro screens have been successfully used to
identify genes required for various cell-based functions, and
we wanted to test whether previously reported RNAi pheno-
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Figure 1 RNAi-based screen to identify components of the Imd signaling cascade in S2 cells. (A) RNAi-mediated gene silencing effectively and
specifically decreases the mRNA level of the targeted gene in S2 cells. A total of 2.5106 S2 cells in six-well plates containing 3 ml of medium
were incubated with or without 10mg of CG5210 dsRNA for 48 h. The expression level of more than 13 500 genes was measured using
Affymetrix Drosophila genechips. Relative expression levels of all genes are shown. Each point represents the average mRNA expression level
of three independent CG5210 RNAi treatments compared pairwise to untreated S2 cells. Arrowhead indicates the dot representing the CG5210
mRNA level. (B) dsRNA treatments targeting ribosomal proteins moderately affect the translation rate of Act5C in S2 cells. Expression of 40
genes coding for ribosomal proteins was silenced using RNAi, and translation rate of Act5C-b-gal was measured in relation to GFP RNAi-treated
controls. Gene-specific b-galactosidase activities were thereafter compared to z-scores reported by Boutros et al (2004). There was a significant
correlation between Act5C-b-gal activities and z-scores (see also Supplementary Table SI). (C) Relish RNAi blocks the Imd pathway activity in a
dose-dependent manner in S2 cells. Att-luc plasmid was used to measure the activity of the Imd pathway and Act5C-b-gal to normalize the
results. A total of 5.0105 S2 cells in 500 ml of medium were treated with the total of 2mg of the indicated dsRNA(s). GFP dsRNA was used as a
negative control. Imd pathway was induced with heat-killed E. coli, and luciferase and b-galactosidase activities were measured 24 h
afterwards. Data are shown as mean7s.d., NX3.
Iap2 and TAB are components of the Imd pathway
A Kleino et al
The EMBO Journal VOL 24 | NO 19 | 2005 &2005 European Molecular Biology Organization3424
types are reproducible in our experimental setting. Recently,
Boutros et al (2004) showed that nearly all dsRNA treatments
targeting genes encoding ribosomal proteins resulted in simi-
lar, rather modest phenotypes. To this end, we carried out
RNAi experiments to silence the expression of 40 genes
coding for ribosomal proteins. We compared the viability of
these cells, using a constitutively active promoter Actin 5C-
driven b-galactosidase reporter (Act5C-b-gal) activity, to the
results of Boutros et al (2004). The result for each individual
gene is shown in Supplementary Table SI. There was a
significant correlation between our b-galactosidase results
and z-scores from Boutros et al (2004; Figure 1B). z-score
measures the severity of RNAi phenotype on cell viability;
z¼ 0 is the average of control dsRNA treatments (no effect on
viability), and the higher the score, the less viable the cells
are. We observed significantly (Po0.0001) lower b-galactosi-
dase values from RNAi treatments targeting ribosomal genes,
which had a z-score 43 compared to those that had a z-score
o2 (Figure 1B). Similarly, dsRNA treatments causing
z-scores 2–3 differed significantly (P¼ 0.006) in their respec-
tive b-galactosidase values from those having z-scores greater
than 3 (Figure 1B). Noteworthy, RNAi experiments silencing
ribosomal proteins caused relatively mild phenotypes (mild
change in b-galactosidase values and z-scores; Figure 1B and
Boutros et al, 2004). These results indicate that RNAi pheno-
types can be reproduced in different experimental settings.
Luciferase-based reporter assay to analyze Imd pathway
activity in S2 cells
Normal response to most Gram-negative bacteria in
Drosophila depends on the Imd pathway, which is very
similar to the TNF receptor signaling pathway in mammals.
In order to determine whether there are still unknown
components in the Imd signaling pathway, we carried out a
large-scale RNAi-based screen in Drosophila S2 cells using
a luciferase-reporter-based quantitative assay. The activity of
the pathway was assayed using Attacin-luciferase (Att-luc)
reporter (Tauszig et al, 2000). Transfection efficiency and cell
viability were monitored using Act5C-b-gal reporter. The Imd
signaling pathway was activated with heat-killed Escherichia
coli. At first, we tested if dsRNA targeting a known compo-
nent of the pathway caused a decrease in Att-luc activity. As
shown in Figure 1C, Relish (Rel) RNAi blocked the Imd
pathway activity in a dose-dependent manner. 10 ng of Rel
dsRNA per 5.0105 S2 cells in 500 ml of medium reduced the
luciferase activity by 450% and more than 0.1 mg of Rel
dsRNA blocked the luciferase activity almost completely
(Figure 1C). Therefore, RNAi very effectively silences the
expression of the targeted gene in our assay, which thus
can be used to identify essential components of the Imd
pathway.
RNAi analysis of gene products regulating the
expression of Attacin via the Imd pathway in S2 cells
We examined 6713 dsRNAs from an S2 cell-derived cDNA
library for their effect on the Imd signaling pathway in S2
cells using Att-luc reporter as a read-out. Most dsRNA treat-
ments had little or no effect. As shown in Table I, seven genes
decreased Att-luc activity by 480% without decreasing
Act5C-b-gal activity by more than 40%, indicating that via-
bility and the translation machinery were unaffected. These
genes included three (PGRP-LC, imd and Rel) out of eight
known components of the Imd pathway. Rel was identified
three times. Novel genes identified were kayak, longitudinals
lacking (lola), inhibitor of apoptosis 2 (Iap2) and CG7417. The
CG7417 protein is a homolog to the mammalian TAK1-bind-
ing proteins 2 and 3 (TAB2 and TAB3), hereafter called TAB.
RNAi targeting these genes did not affect the z-scores in the
study of Boutros et al (2004), further indicating that these
dsRNA treatments have a direct effect on Imd pathway
signaling. Interestingly, a dsRNA treatment silencing Rel,
TAB, PGRP-LC, imd or lola also strongly decreased the
Drosomycin reporter (Drs-luc) activity induced by the consti-
tutively active form of Toll (Toll10b; Table I). Therefore,
it appears that a low level of Rel activity is required also for
normal Drs response via the Toll pathway in S2 cells.
Kayak is a known component of the JNK signaling path-
way; RNAi targeting kayak caused an 8877% decrease in
Att-luc activity (Table I). This is in accordance with our recent
results, which indicate that JNK is essential for normal
antimicrobial peptide release in S2 cells (Kallio et al, 2005).
RNAi targeting lola caused 8775% decrease in Att-luc activ-
ity. Lola is a nuclear factor that is required for axon growth in
the Drosophila embryo (Madden et al, 1999) and normal
phagocytosis of bacteria in S2 cells (Ra¨met et al, 2002). Lola
has not been indicated to play a role in the synthesis
of antimicrobial peptides. In our reporter assay, lola
RNAi decreased Att-luc activity slightly less than known
Table I dsRNA treatments specifically decreasing Att-luc activity (the Imd pathway)
CG# Name N Att-luc Act5C-b-gal N Drs-luc z1a z2a
Mean7s.d. (%) Mean7s.d. (%) Mean7s.d. (%)
CG11992 Rel 3 170 96722 3 3271 0.9 1.3
CG7417 TAB 4 271 97721 6 38710 0.2 0.4
CG8293 Iap2 6 271 120735 3 96724 0 0.3
CG4432 PGRP-LC 4 774 99712 6 3575 0.1 0.5
CG5576 imd 3 771 9975 5 54712 1.6 0.8
CG15509 kayak 2 1277 142782 2 7175 0.1 0.5
CG12052 lola 4 1375 102724 4 26715 0.7 2.1
Act5C-b-gal¼Actin 5C-driven b-galactosidase reporter; Att-luc¼Attacin-luciferase reporter; Drs-luc¼Drosomycin luciferase reporter;
Rel¼Relish; TAB¼TAK1-binding protein; Iap2¼ inhibitor of apoptosis 2; PGRP¼ peptidoglycan recognition protein; lola¼ longitudinals
lacking.
Drs-luc (the Toll pathway) values and z-scores (indicator of cell viability; Boutros et al, 2004) are also shown.
aFrom Boutros et al (2004). z1 and z2 scores show the effect of indicated RNAi on Kc167 cell or S2R
+ cell viability, respectively. The higher the
score, the less viable are the cells (score 0 represents the z-score of control dsRNA-treated cells).
Iap2 and TAB are components of the Imd pathway
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components of the Imd pathway. Of note, RNAi silencing of
lola also decreased Drs-luc activity induced by Toll10b in S2
cells.
In all, 35 dsRNA treatments representing 22 genes caused
a greater than three-fold increase in the Att-luc activity in
response to heat-killed E. coli after ecdysone treatment in S2
cells (Supplementary Table SII). These genes could be divided
into the following categories based on the putative function
of their encoding protein: (1) genes involved in microtubule
organization or actin cytoskeleton regulation (par-1, Rab-
protein 11, multiple ankyrin repeats single KH domain
[mask], a-Tubulin at 84B, CG6509 and PDGF- and VEGF
receptor related [Pvr]); (2) helicases and other genes involved
in DNA replication (Helicase 89B, Rm62, kismet, mutagen-
sensitive 209 and double parked); (3) signaling molecules
(daughter of sevenless, CG32782 and Ecdysone-induced pro-
tein 75B); (4) transcription factors (E2F transcription factor
and Zn-finger homeodomain 1) and (5) uncharacterized
genes. Of note, kismet was identified eight times, Pvr six
times and E2F transcription factor twice in total in our screen.
The mechanisms how these genes affect signaling through
the Imd pathway remain to be studied. Of note, none of these
dsRNA treatments notably induced the Imd pathway without
E. coli (data not shown).
We identified 124 dsRNA treatments representing 83 genes
that decrease Act5C-b-gal activity by 440%. These include
transcription factors, genes required for DNA replication, cell
cycle control, ubiquitination and lipid metabolism, and genes
with unknown function. The complete list of these RNAi
target genes, including Act5C-b-gal values and z-scores from
Boutros et al (2004), is shown in Supplementary Table SIII.
Iap2 and TAB are novel components of the Imd pathway
Importantly, we identified two novel components of the Imd
pathway, Iap2 and TAB, which appear to be absolutely
necessary for induction of Att-luc activity in S2 cells in
response to heat-killed E. coli. dsRNA targeting either Iap2
or TAB caused a drastic, 9871% decrease in Att-luc activity
(Table I). Neither treatment affected S2 cell viability when
assessed using either b-galactosidase activity or z-score
(Table I; Boutros et al, 2004). Furthermore, Iap2 or TAB
RNAi had no effect on cell growth as determined by cell
counts (data not shown), indicating that the result is not due
to increased cell death. To verify that our observed pheno-
types were caused by decreased expression of Iap2 and TAB,
we carried out targeted RNAi with gene-specific primers. As
shown in Figure 2A, specific dsRNA treatments targeting
either Iap2 or TAB drastically decreased the Att-luc activity.
TAB RNAi also decreased the Drs reporter activity via the
Toll10b-induced Toll pathway (Table I and Figure 2A). We
also examined whether the effect of Iap2 or TAB RNAi was
ecdysone dependent. If ecdysone was not used, Att-luc
induction was clearly (3572%, N¼ 3) weaker, but also
this induction was blocked by RNAi targeting either Iap2 or
TAB (data not shown), indicating an ecdysone-independent
mechanism.
To ascertain that our results were not due to an artifact
related to the use of a reporter construct, we analyzed the
expression level of Cecropin A1 (CecA1), another well-char-
acterized antimicrobial gene regulated by the Imd pathway,
by semiquantitative RT–PCR. As shown in Figure 2B, a 6-h
exposure to heat-killed E. coli increased the mRNA level of
CecA1. This increase could be blocked entirely by RNAi
targeting either Rel or TAB. In addition, induction was
reduced by RNAi targeting Iap2. Corresponding results were
obtained also for Att D and Diptericin (Dpt). dsRNA treat-
ments targeting either Rel or TAB totally blocked the induc-
tion, while the effect of Iap2 RNAi was somewhat more
moderate (data not shown).
To investigate whether these in vitro findings are of in vivo
relevance, we used the inducible expression of Iap2 dsRNA in
Drosophila in vivo. The UAS/GAL4 binary system to drive
expression of dsRNA in a defined tissue has been previously
used to block the expression of defined genes (Kennerdell and
Carthew, 2000; Leulier et al, 2002). To this end, we generated
transgenic flies carrying the UAS-Iap2-IR. This construct has
two 500 bp long inverted repeats (IR) of the gene, separated
by an unrelated DNA sequence that acts as a spacer, to give
a hairpin-loop-shaped RNA. These transgenic flies were
crossed to flies carrying various GAL4 drivers in order to
activate transcription of the hairpin-encoding transgene in
the progeny. Iap2 has been shown to be required for the
regulation of apoptosis in Drosophila (F Leulier, personal
communication, 2005), and overexpression of UAS-Iap2-IR
with the ubiquitous and strong daughterless-GAL4 (da-GAL4)
driver lead to lethality at the pupal stage. To address the role
of Iap2 in antimicrobial gene expression, we expressed the
UAS-Iap2-IR transgene using the C564-GAL4 driver that ex-
presses GAL4 in the adult fat body. Flies were kept at 251C to
avoid the induction of apoptosis in the fat body. Flies that
express Iap2-IR ubiquitously through C564 showed no detect-
able defects. However, the expression of the antibacterial
peptide gene Dpt was strongly reduced after infection with
the Gram-negative bacteria Erwinia carotovora (Figure 2C).
This phenotype was similar, although weaker, than those
generated by BG4-IR RNAi. Importantly, the expression of Drs
remained inducible in Iap2-IR; C564 flies, indicating that Iap2
did not block the Toll pathway and that the fat body remained
functional.
Iap2 and TAB are both located downstream of Imd
To map the locations of Iap2 and TAB in the Imd signaling
cascade, we overexpressed known components of the cas-
cade including a constitutively active form of Relish (Rel
DS29–S45), wild-type Relish or wild-type Imd (Figure 3A).
All these caused an activation of Att expression in S2 cells.
Att induction caused by expression of either Relish construct
could not be blocked by RNAi targeting either imd, TAB or
Iap2, indicating that both TAB and Iap2 are located upstream
of Relish (Figure 3A). On the other hand, Att induction
caused by overexpression of Imd was blocked by RNAi
targeting either Rel, imd, TAB or Iap2, indicating that both
TAB and Iap2 lie downstream of Imd in the hemocyte-like
S2 cells.
To assess whether Iap2 is located downstream of Imd in
the fat body in vivo, we overexpressed the UAS-imd construct
with a heat-shock-GAL4 (hs-GAL4) driver, which induces
expression of the Dpt gene in the absence of infection.
Although there is some constitutive Dpt expression in these
flies, the level of Dpt increases after heat shock. Using these
flies, Dpt expression was reduced by coexpression of UAS-
Iap2-IR by 4478% (N¼ 2) in these flies. Total RNA was
extracted from unchallenged adult flies, collected 6 or 16 h
after a heat shock (371C, 1 h) and RT–PCR analysis was used
Iap2 and TAB are components of the Imd pathway
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to monitor the expression level of Dpt. This indicates that
Iap2 functions, genetically, downstream of Imd in the fat
body in vivo.
To map the exact location of Iap2 in the Imd signaling
cascade, we overexpressed Iap2 in S2 cells, which resulted in
a minimal but reproducible induction of Att expression
(Figure 3B). This induction was completely blocked by
dsRNAs targeting the known components of the Imd path-
way, except dsRNAs targeting either imd or TAK1. These
results indicate that Iap2 lies downstream of TAK1 in the Imd
signaling pathway. To ascertain efficacies of the dsRNA
treatments used, we simultaneously measured their effect
on E. coli-induced Att response (Supplementary Figure S1).
All of the dsRNA treatments strongly decreased the Att
response, suggesting that the expression of targeted genes
was effectively silenced. Of note, we were unable to stimulate
the Imd pathway with the expression vector containing the
full-length cDNA of TAB.
120
R
el
at
iv
e 
lu
ci
fe
ra
se
 a
ct
ivi
ty
(%
 of
 G
FP
 
co
n
tro
ls
)
The lmd pathway The Toll pathway
100
80
60
40
20
0
Toll10b
dsRNA
dsRNA
GFP (µg)
IAP2 (µg)
TAB (µg)
Relish (µg)
Myd88 (µg)
CecA1
Act5C
E. coli
GFP GFP Rel TAB lap2
Reporter
Attacin-Luc
Drosomycin -Luc
E. coli
+ +
+ + + + + + + +
1 1
1
1
1
+ + +
+ + + +
+ + + + +
+ + + +
−
−
− − − −
− − − − −−
−
− −
− − − −
− − −
− −
−
− −
− −
−
− − −
−
− − − −
−
− − − − −
1 1
1
1
1
− − −
− −
−
− −
− − −
− − − −
− − − −
−
Diptericin (the lmd pathway)
Drosomycin (the Toll pathway)
P=0.04 P <0.01
100
80
60
R
el
at
iv
e 
m
R
N
A 
le
ve
l
(%
 of
 co
ntr
ols
)
40
20
0
5
Wild type
3 5 34 3N
UAS-lap2-IR UAS-BG4-IR
B C
A
Figure 2 Targeted RNAi of Iap2 or TAB reduces the Imd pathway activity. (A) The effect of targeted Iap2 or TAB RNAi on Imd and Toll
pathways. S2 cells were transfected either with Att-luc (the Imd pathway) or with Drs-luc reporter plasmid together with Toll10b (the Toll
pathway). Act5C-b-gal reporter was included to control transfection efficiency and viability. dsRNA (2mg) was added directly to transfection
medium. For Imd pathway, the transfected cells were incubated with ecdysone (day 3) prior to the addition of heat-killed E. coli (day 4), after
which the Att-luc activity was measured on day 5. The Drs-luc activity (Toll pathway) was measured on day 4 after transfection. Data are
shown as mean7s.d., NX3. (B) CecA1 induction is inhibited by dsRNA treatments targeting either TAB or Iap2. S2 cells were treated with 20 mg
of indicated dsRNA and ecdysone was added 48 h later. After 24 h, the cells were exposed to heat-killed E. coli for 6 h, after which the total RNA
was extracted. RT–PCR analysis was used to monitor the expression level of CecA1. Each treatment was carried out in duplicate. (C) Iap2
regulates the expression of antibacterial peptide gene Diptericin in Drosophila adults. Quantitative RT–PCR analysis was performed with total
RNA extracts from wild-type (C564/þ ) flies and flies overexpressing the UAS-Iap2-IR or UAS-BG4-IR females with C564. Diptericin expression
was monitored in flies collected 6 h after septic injury with E. carotovora, while Drs was monitored in flies collected 24 h after septic injury with
M. luteus. Number of experiments (N) is shown.
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Iap2 and TAB appear to be involved in nuclear
localization of Relish but are not required for cleavage
Upon Imd pathway activation, the NF-kB homolog Relish
becomes phosphorylated by the IKK complex and thereafter
cleaved by a caspase putatively thought to be Dredd. Finally,
Relish is translocated to the nucleus. To study the role of TAB
and Iap2 on Relish cleavage, we stimulated Drosophila
hemocyte-like mbn-2 and S2 cells with commercial lipopoly-
saccharide (LPS) known to contain a bacterial component
that activates the Imd pathway, followed by Western blotting
with Relish antibody (a-C; Sto¨ven et al, 2000). As shown in
Figure 4A, in unstimulated, GFP dsRNA-treated mbn-2 cells,
most of Relish is uncleaved (Relish-110 (REL-110)), whereas
upon LPS stimulus, Relish cleavage is induced. As expected,
in Dredd and key dsRNA-treated cells Relish cleavage was
blocked. Interestingly, TAB, Iap2 or TAK1 dsRNA did not
affect Relish cleavage (Figure 4A). Similar results were ob-
tained also in S2 cells (Figure 4B and data not shown). This
points to a novel mechanism of regulation of Relish activity.
There was no Relish detected in Rel dsRNA-treated cells,
indicating that the half-life of REL-49 (C-terminal Relish
cleavage product) is less than the duration of the dsRNA
treatment. Of note, REL-49 was observed also in all Dredd
dsRNA-treated cells. It is possible that after RNAi knock-
down, there is a small amount of Dredd left, sufficient to
cleave REL-110 in unstimulated cells. Alternatively, there
is some constitutively cleaved Relish in cell lines and this
cleavage is Dredd independent.
To investigate whether Iap2 or TAB play a role in the
nuclear localization of the activated Relish protein, dsRNA-
treated S2 cells were stained with a-RHD antibody (Sto¨ven
et al, 2000). In GFP dsRNA-treated cells, Relish is translocated
into the nucleus upon LPS stimulus (Figure 4C). As expected,
there is no nuclear staining of Relish in Dredd or key dsRNA-
treated, LPS-stimulated S2 cells. Importantly, the nuclear
translocation of Relish appears to be affected in both Iap2
and TAB dsRNA-treated cells compared to GFP dsRNA-treated
controls (Figure 4C). This suggests that cleavage of Relish is
not sufficient for translocation of Relish to the nucleus but
another, yet to be characterized signal that is propagated via
Iap2 and TAB is required. Alternatively, different staining
pattern could be due to decreased stability of nuclear Relish
or slower kinetics. Of note, compared to key and Dredd
dsRNA-treated cells, very faint nuclear staining can be seen
in Iap2 dsRNA-treated cells. Surprisingly, Relish nuclear
localization was normal in TAK1 dsRNA-treated cells. This
implies a possibility that the role of TAK1 in the Imd pathway
signaling is downstream of translocation of Relish into the
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nucleus. Altogether, these result show that the regulation of
Relish activity is more complex than previously thought. The
involvement of TAB and Iap2 in nuclear localization but not
cleavage of Relish indicates a novel mode of regulation in the
Imd pathway.
Iap2 and TAB both have mammalian homologs
Iap2 codes for a 498 amino-acid (aa) protein that has three
N-terminal BIR (baculovirus IAP repeat) domains and a
C-terminal RING-finger (Really Interesting New Gene)
domain. Drosophila Iap2 is well conserved throughout
phylogeny and has high sequence similarity with many
mammalian Iap2s, such as human, rat and mouse (E values
91066, 21066 and 31066, respectively). Interestingly,
the CARD (caspase recruitment) domain, identified in apop-
totic signaling proteins, is present in the mammalian homo-
logs but missing from Drosophila. An alignment highlighting
conserved domains is shown in Figure 5A. It has been shown
that RING domain containing proteins, including IAPs, bind
E2 ubiquitin-conjugating enzymes catalyzing the transfer
of ubiquitin from E2 to a substrate, therefore acting as E3
ligases. Ubiquitination can lead to either proteasomal degra-
dation, or, in the case of non-K48-linked polyubiquitination,
to multiple outcomes such as activation or relocalization of
the substrate protein (Vaux and Silke, 2005). Human c-Iap2 is
expressed most strongly in immune tissues including spleen
and thymus and has been proposed to associate with TRAFs
through its BIR domains (Rothe et al, 1995). However, in our
luciferase assay, neither TRAF1 nor TRAF2 dsRNA treatment
reduced the Imd pathway activity, indicating that TRAFs are
not essential for Imd pathway activity in Drosophila S2 cells.
The Drosophila TAB codes for an 831 aa protein that has an
N-terminal CUE domain (97–139 aa) and a C-terminal zinc-
finger (ZnF) domain (765–789 aa). Only two other Drosophila
genes code for a CUE domain: CG2701, and CG12024. Their
function is unknown. TAB is the only Drosophila protein with
both CUE and ZnF domains. These domains are homologous
to the respective domains in mammalian TABs (Figure 5B).
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The CUE domain carries a ubiquitin-binding motif, whereas
the ZnF domain has an a-helical coiled-coil region. It has
been shown that Drosophila TAK1 binds TAB (CG7417) in a
two-hybrid protein interaction system (Giot et al, 2003). In
humans, the C-terminal coiled-coil domain of TAB3 mediates
the association with TAK1, and it is also required for stimula-
tion of TAB3 ubiquitination by TRAF6 (Ishitani et al, 2003).
Apart from these two domains, there is very little sequence
similarity, suggesting that these domains are functionally
important. Indeed, it has been shown that the ZnF domain
and the CUE domain, to a lesser extent, of human TAB2 and
TAB3 are important to NF-kB activation (Kanayama et al,
2004). Our current hypothesis of signaling via the Imd path-
way in Drosophila is shown schematically in Figure 6. The
exact molecular mechanism by which Iap2 and TAB modu-
late signaling via the Imd pathway in Drosophila remains to
be studied.
Conclusion
RNAi has proven to be an efficient method specifically to
silence targeted genes and it has been successfully used in
large-scale screens of gene function in Drosophila cells
(Ra¨met et al, 2002; Lum et al, 2003; Boutros et al, 2004). In
this study, we have shown that RNAi is both effective and
extremely specific in our experimental setting. Thereafter, we
carried out a blind screen for B6700 dsRNAs. We identified
altogether 29 gene products that played a role in the Imd
pathway signaling in S2 cells. Several housekeeping genes
that are required for normal Act5C promoter-driven b-galac-
tosidase expression were also identified. We found three out
of eight previously known components of the Imd pathway.
We were unable to find five known components from our
screen including TAK1, kenny, ird5, BG4 and Dredd. Of note,
targeted RNAi treatments silencing these genes resulted in
strongly reduced Att promoter activity in our experimental
setting. Therefore, we believe that those genes were not
present in our dsRNA collection.
We observed very few dsRNA treatments that reduced Att-
luc activity by more than 80% without significantly affecting
the viability of S2 cells as assayed by Act5C-b-gal activity.
This differs from the results reported recently by Foley and
O’Farrell (2004), who found 49 genes from their RNAi screen
to be required for normal Dpt response. Fewer genes identi-
fied by us could simply reflect the smaller number of dsRNA
treatments analyzed in our study. However, if we had not
used an internal control (namely Act5C-b-gal expression), to
exclude genes that have a more generalized effect on S2 cell
homeostasis, we would have had a much greater number of
genes putatively affecting the Att expression. Our quantita-
tive and reproducible assay let us use a strict threshold that
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Figure 5 Iap2 and TAB are conserved throughout phylogeny. (A) Comparison of the deduced amino-acid sequences of Iap2 homologs from rat
(Rattus norvegicus, AAH62055.1), mouse (Mus musculus, AAC53532.1), human (Homo sapiens, NP_001157.1) and Drosophila melanogaster
(AAF58095.1). The three conserved BIR domains are boxed and shown in bold; CARD domain (missing from Drosophila) is shown in lower
case and italicized; the RING domain in the C-terminus is boxed and italicized. (B) Alignment of Drosophila TAB with human TAK1-binding
protein 3 (AAQ88279.1) and mouse TAK1-binding protein 2 (NP_619608.1). CUE (97–139) and ZnF (765–789) domains are shown boxed and in
bold. The low complexity region (157–720) showing no homology with other TABs is not shown. Alignments were created using ClustalW
program.
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allowed us to identify true components of the Imd pathway.
There may also be differences in our S2 cells and those used
by Foley and O’Farrell (2004) that explain the different set of
genes identified in these two studies. This is supported by the
notion that targeted dsRNA treatments silencing either Act5C,
SCAR or Dnr1, reported to activate the Imd pathway by Foley
and O’Farrell (2004), did not cause induction of Att promoter
in our assay. The effectiveness of the SCAR and Act5C
dsRNAs was evaluated by measuring the rate of phagocytosis
of E. coli and was found to be reduced as expected (Ra¨met
et al, 2002; Pearson et al, 2003). Of note, our results are
in agreement with current results from the laboratory of
M Boutros (Gesellchen et al, EMBO Reports, in press) who
also screened for new components of the Imd pathway in
Drosophila S2 cells.
Importantly, we were able to identify two novel compo-
nents of the Imd signaling cascade: Iap2 and TAB. Both of
these have mammalian homologs, further indicating high
conservation of this signaling cascade. TAB is an 831 aa
protein that has conserved CUE and ZnF domains. As in
mammals, it is plausible that TAB regulates TAK1 activity
also in Drosophila, as TAB was the only protein to bind TAK1
in a two-hybrid protein interaction system (Giot et al, 2003).
We have shown that both Iap2 and TAB are located
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downstream of Imd. Interestingly, Relish is cleaved appro-
priately without Iap2 or TAB, but there appears to be an effect
to the transportation of Relish to the nucleus. Therefore, we
speculate that there is another, previously unidentified level
of regulation needed for Relish activation. Since the RING
domain-containing Iap2 is a putative E3 ligase, we hypo-
thesize that this regulation could involve ubiquitination of
Relish—or another protein regulating the activity of Relish—
by Iap2. Possible interaction of Iap2 with the other Imd
pathway components remains to be studied.
Surprisingly, Relish nuclear localization was normal in
TAK1 dsRNA-treated cells. This implies a possibility that the
role of TAK1 in the Imd pathway signaling is downstream of
translocation of Relish into the nucleus. Our results are in line
with recent results from J Delaney et al (in preparation),
which indicate that Relish activation is intact in TAK1 mutant
flies. Therefore, TAK1 may control the activity of another
transcription factor—possibly via the JNK pathway—re-
quired for normal antimicrobial peptide response in
Drosophila. This is in line with identification of Kayak as an
important factor for Att response in this study and with our
earlier results indicating that the JNK pathway is required for
normal Att response in S2 cells (Kallio et al, 2005). Of note,
the effect of dsRNA treatments targeting JNK pathway com-
ponents is more modest compared to TAK1 RNAi in our
experimental setting. This is in line with the earlier results
of Silverman et al (2003), who showed that in S2* cells TAK1
RNAi totally blocks Dpt, Cecropin and Att response to LPS,
whereas RNAi targeting JNK pathway components hemipter-
ous and basket have more moderate effect. Nevertheless, the
regulatory interplay that has been detected between the Imd
and the JNK pathway in the Drosophila innate immune
response (Boutros et al, 2002; Park et al, 2004) is likely to
attract more attention in the future.
This present study underlines the convenience of RNAi-
based screening in S2 cells. Importantly, we identified two
novel components of the Imd pathway. The exact roles Iap2
and TAB play in the activation of Relish remain to be solved.
In addition, our findings will likely focus attention to inves-
tigate the importance of Iap2 in mammalian TNF receptor
signaling. This methodology can be readily applied to study
other conserved signaling cascades.
Materials and methods
Synthesis of dsRNAs
A cDNA library derived from S2 cells cloned into pcDNAI plasmids
(Invitrogen) (Pearson et al, 1995) was used as a source for
templates for dsRNA synthesis. First, competent MC1061/P3 E. coli
(Invitrogen) transformed with the cDNA library were plated onto
ampicillin (20mg/ml) and tetracycline (8mg/ml) containing plates.
Then, plasmids from individual colonies were isolated and the
random gene products from the cDNA library were amplified by
two-stage PCR. The following outer primers were used:
50-CAAGCTTGGTACCGAGCTC-30 and
50-CTGCTCCCATTCATCAGTTC-30.
In the nested PCR, the binding sites for T7 RNA polymerase were
included in both ends of PCR primers. The following nested primers
were used:
50-TAATACGACTCACTATAGGGCGGATCCACTAGTAACGG-30 and
50-TAATACGACTCACTATAGGGAGGTGACACTATAGAATAGG-30.
Control dsRNAs were produced using targeted RNAi primers (see
Supplementary Table SIV). cDNA from S2 cells was used as
template essentially as described earlier (Ra¨met et al, 2001).
Negative control GFP dsRNA was produced using pMT/BiP/V5-
His/GFP plasmid (Invitrogen) as template. dsRNAs were produced
from the nested PCR templates by in vitro transcription using the T7
MegaScript RNA polymerase (Ambion) according to the manufac-
turer’s instructions. dsRNA for CG5210 was created by cloning a
PCR fragment of 698 bp into pCR-Blunt II-TOPO (InVitrogen), using
the following primers: CCCAAGAATAAGCCGAAGAA and CTCACC
CAGATGCCATTGT. Purified plasmid DNA was cut with HindIII or
XbaI and used to template in vitro RNA synthesis with T7 or SP6
RNA polymerase (Ambion), respectively.
Cell culture, dsRNA treatments and luciferase reporter assay
S2 cells were cultured in Schneider medium (Sigma)þ 10% FBS,
100 U/ml penicillin and 100mg/ml streptomycin at 251C. Mbn-2
cells were cultured in Schneider mediumþ 10% FBS and 10 mM
L-glutamine (Sigma) at 251C. Luciferase reporter assays were
performed essentially as described earlier (Ra¨met et al, 2001; Kallio
et al, 2005). Briefly, for Imd pathway, S2 cells were transfected with
Attacin-luc reporter (Tauszig et al, 2000), Actin 5C-b-galactosidase
and dsRNAs using Fugenes transfection reagent (Roche) according
to the manufacturer’s instructions. Ecdysone (1 mM, Sigma;
Dimarcq et al, 1997) was added 48 h after transfection and the
pathway induced with heat-killed E. coli 60 h after transfection. At
90 h after transfection, S2 cells were harvested by centrifugation
and lysed in Passive Lysis Buffer (Promega). For Toll pathway, S2
cells were transfected with Toll10b, a constitutively active form of
Toll receptor (Rosetto et al, 1995), Drosomycin-luciferase reporter,
Actin 5C-b-galactosidase and dsRNAs as above. Luciferase and b-
galactosidase activities were measured using standard procedures.
Data analysis
The ratio of luciferase activity and b-galactosidase activity per
sample was calculated and the values from each series were
normalized by setting the value of the lysate from S2 cells treated
with GFP dsRNA to one. b-galactosidase activity was normalized by
dividing the values by the average of all b-galactosidase measure-
ments. Tested dsRNA treatments were sorted into three groups: (1)
dsRNAs decreasing luciferase activity but not significantly affecting
b-galactosidase activity (Luc/b-galp0.2 and b-gal/b-galX0.6), (2)
dsRNAs increasing luciferase activity but not significantly affecting
b-galactosidase activity (Luc/b-galX3.0 and b-gal/b-galX0.6) and
(3) dsRNAs decreasing b-galactosidase activity (b-gal/b-gal p0.6).
Statistical analysis of results was carried out using one-way ANOVA.
Po0.05 was considered to be significant.
Genome-wide analysis of mRNA levels using oligonucleotide
microarrays
Total RNA was extracted from 1.0107 S2 cells using RNeasy Mini
Kit (Qiagen, CA, USA). Gene expression analysis was performed
using the Affymetrix (Santa Clara) Drosophila Genechips according
to the standard Affymetrix GeneChip protocol as outlined in the
GeneChip Expression Analysis Technical Manual by Affymetrix
(2001). Gene expression levels of three CG5210 RNAi-treated S2
cells were compared pairwise to untreated S2 cells.
Sequencing
DNA was purified from PCR reactions with GENECLEAN Turbo Kit
(QBiogene) or from an agarose gel with QIAquick Gel Extraction Kit
(Qiagen). The samples were prepared for the sequencing with ABI
BigDye terminators (Applied Biosystems), essentially as recom-
mended by the manufacturer. Excess dye-labeled terminators and
buffers were removed by ethanol/EDTA precipitation, and DNA
sequencing was performed with an ABI 3100 automated sequencer
(Applied Biosystems).
RT–PCR for assaying CecA1 mRNA level
A total of 1.5106 S2 cells were seeded onto six-well plates and
treated with 20mg of sample or control dsRNA. Ecdysone (1 mM,
Sigma) was added 48 h after dsRNA treatment. Antimicrobial
peptide release was induced by heat-killed E. coli treatment (4 h),
after which the total RNA was extracted, 72 h after the dsRNA
treatment, with TRIzols Reagent (Invitrogen) according to manu-
facturer’s instructions. cDNA synthesis was carried out as follows:
Template RNA, Oligo(dT)-primer (20 ng/ml) and M-MuLV-buffer
were mixed, incubated at 701C for 5 min and cooled. dNTP (final
conc. 1 mM), RNAse inhibitor (20 U, Fermentas) and RNAse free
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H2O were added and the mixture incubated at 251C for 5 min, after
which the M-MuLV reverse transcriptase enzyme (20 U, Fermentas)
was added and the mixture incubated for 60 min at 371C. Finally,
the mixture was denatured at 951C for 5 min, cooled and stored
at 701C. PCR reactions for CecA1 and Act5C were carried out
according to manufacturer’s instructions using the synthesized
cDNAs as templates. Primers and sizes of PCR products are listed in
Supplementary Table SIII.
Fly stocks
RNAi transgenic fly lines of Iap2 were obtained using the inducible
RNAi method. A cDNA fragment corresponding to the first 500 bp
of the coding sequence was amplified by PCR, and inserted as an
IR in a modified transformation vector (pUAST-R57) possessing an
IR formation site consisting of paired KpnI–CpoI and XbaI–SfiI
restriction sites. pUAST-R57 has a 282-bp-long genome fragment of
the Drosophila Ret oncogene, in which introns 5 and 6 are
contained, between two IR fragments to enhance RNAi effect
(Kalidas and Smith, 2002). The IR was constructed in a head-to-
head orientation by using a combination of tag sequences of PCR
primers and restriction sites on the vector. Detailed cloning
procedures will be described elsewhere (R Ueda et al, manuscript
in preparation). Transformation of Drosophila embryos was carried
out in w1118 fly stock. Each experiment was repeated using two
independent UAS-RNAi insertions. The BG4-IR (dFADD-IR) fly line
has been described previously (Leulier et al, 2002). In this study, we
used adult flies carrying one copy of the UAS-RNAi construct
combined with one copy of the GAL4 driver. The C564-GAL4 driver
expresses strongly GAL4 in adult hemocytes and fat body.
Infection
Bacterial infections were performed by pricking adults with a thin
needle dipped into a concentrated culture of bacteria. Details on
infection are described elsewhere (Tzou et al, 2002; Pili-Floury et al,
2004).
Quantitative real-time PCR
For Drs and Dpt mRNA quantification from whole animals, RNA
was extracted using RNA TRIzols Reagent and cDNAs were
synthesized using SuperScript II (Invitrogen). Primer pairs used
are listed in Supplementary Table SIV. SYBR Green analysis was
performed on a Lightcycler (Roche). All samples were analyzed in
duplicate and the amount of mRNA detected was normalized to
control RP49 mRNA values. Normalized data were used to quantify
the relative levels of a given mRNA as described in Pili-Floury et al
(2004).
Overexpression of Iap2 in S2 cells
Full-length Iap2 cDNA (LD34777), obtained from Drosophila
Genomics Resource Center (DGRC; Indiana, USA), was subcloned
into EcoRI and XhoI sites of the Drosophila expression vector pMT/
BiP/V5/HisA. E. coli TOP10 cells were transformed with the
construct and grown under ampicillin selection. After identification
of the right clone by EcoRI and XhoI digestion, the plasmid was
extracted and used (0.5mg/well) in transfection together with Att-
luc, Act5C-b-gal and dsRNAs as described previously. Overexpres-
sion of the Iap2 protein was induced by adding CuSO4 (500mM) 48 h
after transfection. Luciferase and b-galactosidase activities were
measured 48 h later and data analysis was carried out as described
previously.
Immunohistochemistry
Cells were seeded on a 24-well plate and treated with dsRNAs (4 mg/
well, by soaking) for 72 h. Relish cleavage was induced with LPS
(final concentration of 10 mg/ml) for 10 min, after which the cells
were spun onto glass slides, fixed and labeled with a-RHD antibody
as described previously (Sto¨ven et al, 2000).
Protein extraction, SDS–PAGE and Western blotting
Cells were seeded onto six-well plates and treated with control or
experimental dsRNAs (20 mg/well) for 72 h. Relish cleavage was
induced by incubating the cells with LPS (10mg/ml) for 30 min.
Cells were placed on ice and protein lysates prepared as described
previously (Sto¨ven et al, 2003). In all, 25mg of protein per sample
was used for SDS–PAGE. Electrophoresis and immunoblotting with
a-C antibody was carried out as described previously (Sto¨ven et al,
2000).
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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